United States · 
What does NYBC Ventures invest in?
NYBC Ventures invests most often at Growth and Series B (100% of the rounds on record), in sectors such as Hematology, Transfusion Medicine and Cell Therapy.
NYBC Ventures highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Growth and Series B: 100% of its rounds
What they do
NYBC Ventures, launched by New York Blood Center Enterprises (NYBCe) with a $50M commitment, drives innovation in blood-related fields, cellular therapies, and related technologies.From their own website
- Type
- Corporate VC
- Cheque size
- Not stated
- Stages
- SeedSeries A
- Sectors
- HematologyTransfusion MedicineCell Therapy
- Based in
- New York, United States
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first5 appearances
- 2026
2 rounds
- Oct
- Jun
- 2025
1 round
- Jun
- 2024
1 round
- Nov
- 2023
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
What they claim to have backed
From their own portfolio page (on their website)
7 of 14 we have independently watched raise
AvencellCellularoriginsFunctionalfluidicsImmusoftKalocyteStrmVitestroAkadeumAronorabioHealthquestcapitalNam10New York BloodThymmuneVega-therapeutics
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.